Advanced Search

    column
    The Consensus of Small Cell Lung Cancer Management
    WU Yi-long, LIAO Mei-lin, ZHOU Qing-hua, CHENG Ying, WANG Chang-li, WANG Lü-hua, LU Shun, FU Xiao-long, ZHOU Cai-cun, HUANG Cheng, Tony SK Mok, LUO Dong-lan, YANG Xue-ning, WANG Jie, CHEN Hai-quan, LU You, WANG Jun, MA Sheng-lin, XU Lin, MAO Wei-min, FENG Ji-feng, SONG Qi-bin, WU Gang, ZHU Guang-ying, WANG Zhen
    2012, 12(2): 65-69. DOI: 10.3969/j.issn.1671-5144.2012.02.001
    Abstract FullText HTML PDF
    An Interview at 2012 Chinese Lung Cancer Summit Forum
    YU Lin, ZHANG Hua
    2012, 12(2): 70-81. DOI: 10.3969/j.issn.1671-5144.2012.02.002
    Abstract FullText HTML PDF
    2012, 12(2): 82-82. DOI: 10.3969/j.issn.1671-5144.2012.02.003
    Abstract FullText HTML PDF
    ,
    2012, 12(2): 82-82. DOI: 10.3969/j.issn.1671-5144.2012.02.004
    Abstract FullText HTML PDF
    , ,
    2012, 12(2): 83-83. DOI: 10.3969/j.issn.1671-5144.2012.02.005
    Abstract FullText HTML PDF
    ,
    2012, 12(2): 83-83. DOI: 10.3969/j.issn.1671-5144.2012.02.006
    Abstract FullText HTML PDF
    2012, 12(2): 84-84. DOI: 10.3969/j.issn.1671-5144.2012.02.008
    Abstract FullText HTML PDF
    ,
    2012, 12(2): 84-84. DOI: 10.3969/j.issn.1671-5144.2012.02.007
    Abstract FullText HTML PDF
    New Progress in Treatment of Primary Hepatocellular Carcinoma
    OU Jin-rui, WANG Hui-ling
    2012, 12(2): 85-88. DOI: 10.3969/j.issn.1671-5144.2012.02.009
    Abstract FullText HTML PDF
    Multi-Center Studies Barcelona Clinical Staging and Liver Cancer Patients Liver Transplant Survival Benefit Evaluation of Forecasting Models
    ZHOU Jie, YANG Dong-yang
    2012, 12(2): 89-91. DOI: 10.3969/j.issn.1671-5144.2012.02.010
    Abstract FullText HTML PDF
    Systematic Review of Survival and Disease Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
    GUO Rong-ping, LI Ying
    2012, 12(2): 92-95. DOI: 10.3969/j.issn.1671-5144.2012.02.011
    Abstract FullText HTML PDF
    Survival after Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma: A Meta-Analysis
    JIAN Zhi-xiang, JIN Hao-sheng
    2012, 12(2): 96-98. DOI: 10.3969/j.issn.1671-5144.2012.02.012
    Abstract FullText HTML PDF
    Phase Ⅲ Study of Sorafenib after Transarterial Chemoembolisation in Japanese and Korean Patients with Unresectable Hepatocellular Carcinoma
    MENG Qing-wen, LU Li-gong
    2012, 12(2): 99-102. DOI: 10.3969/j.issn.1671-5144.2012.02.013
    Abstract FullText HTML PDF
    The Safety and Efficacy of High-Dose Proton Beam Radiotherapy for Hepatocellular Carcinoma: A Phase Ⅱ Prospective Trial
    LI Wei-xiong, ZENG Zi-jun
    2012, 12(2): 103-105. DOI: 10.3969/j.issn.1671-5144.2012.02.014
    Abstract FullText HTML PDF
    Comparation of Doxorubicin plus Sorafenib to Doxorubicin Alone in Patients with Advanced Hepatocellular Carcinoma
    MA Dong, DONG Qiu-mei, LIU Jian-hua
    2012, 12(2): 106-108. DOI: 10.3969/j.issn.1671-5144.2012.02.015
    Abstract FullText HTML PDF
    Circulating MicroRNA-21 as A Novel Biomarker for Hepatocellular Carcinoma
    HUANG Yuan-yuan, YANG Qiong, XIE De-rong, YANG Li-hui
    2012, 12(2): 109-111. DOI: 10.3969/j.issn.1671-5144.2012.02.016
    Abstract FullText HTML PDF
    A Meta-Analysis of Association of Mycoplasma Fermentans and HIV Infection
    JIN Hui, GAO Qian, WU Jian-ru, WANG Bei
    2012, 12(2): 112-116. DOI: 10.3969/j.issn.1671-5144.2012.02.017
    Abstract FullText HTML PDF
    Systematic Review of GLP-1 Analogues—Liraglutide for Type 2 Diabetes Mellitus
    YAN Xin, DENG Hong-ming, XIAO Chang-qing
    2012, 12(2): 117-124. DOI: 10.3969/j.issn.1671-5144.2012.02.018
    Abstract FullText HTML PDF
    Meta-Analysis of Ordinal Data and Its Solution by SAS
    ZHANG Tian-song, XIONG Qian
    2012, 12(2): 125-128. DOI: 10.3969/j.issn.1671-5144.2012.02.019
    Abstract FullText HTML PDF